 Imagio is expected to identify two functional hallmarks of a potential malignancy: the presence of abnormal blood vessels angiogenesis; and the relative reduction in oxygen content of hemoglobin. The technology is non-invasive and does not require any contrast agent or radio-isotope, which is required for other modalities such as MRI or PET. 